Search
for
Sort by
Research 241–270 of 1000+
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways
- Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Androgens in cervical cancer: Their role in epidemiology and biology
- Xinyang tablet ameliorates sepsis-induced myocardial dysfunction by regulating Beclin-1 to mediate macrophage autophagy and M2 polarization through LncSICRNT1 targeting E3 ubiquitin ligase TRAF6
- The emerging roles of N6-methyladenosine (m6A) deregulation in polycystic ovary syndrome
- Advances and Perspectives on Bioelectronic and Atomic Nanogenerators for Anticancer Therapy
- SMC-specific IGF1 suppresses a 45 kDa LAMP2 isoform to mediate the anti-atherosclerotic effect of ferulic acid
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Recent Updates of the CRISPR/Cas9 Genome Editing System: Novel Approaches to Regulate Its Spatiotemporal Control by Genetic and Physicochemical Strategies
- Recent Progress and Morphological Distribution of Polydopamine-Based Biomaterials and Their Applications
- Wound Healing Impairment in Type 2 Diabetes Model of Leptin-Deficient Mice—A Mechanistic Systematic Review
- Cytokine Engineering Approaches for Regenerative Medicine
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Exploring the therapeutic potential of phytochemicals apigenin and ellagic acid in managing polycystic ovarian syndrome and its comorbidities: a comprehensive review
- Phytochemical and Therapeutic Evaluation of Curcumin and Piperine in Alopecia
- Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonine
- Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options
- Drug Discovery Today: Therapeutic Strategies - 2006 Editorial
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Therapeutic Application of Microsponges-based Drug Delivery Systems
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases